Reaffirming revenue guidance, especially when it aligns with analysts' expectations, typically instills confidence in investors about the company's future performance and stability. For 10x Genomics, maintaining its revenue outlook in the face of market uncertainties can be seen as a positive signal, likely leading to a favorable short-term impact on its stock price.